Nowakowska, J.; Sobkowiak, P.; Bręborowicz, A.; Mrówczyńska, M.; Wojsyk-Banaszak, I.; Szczepankiewicz, A.
Nitric Oxide Synthase 2 Promoter Polymorphism Is a Risk Factor for Allergic Asthma in Children. Medicina 2021, 57, 1341.
https://doi.org/10.3390/medicina57121341
AMA Style
Nowakowska J, Sobkowiak P, Bręborowicz A, Mrówczyńska M, Wojsyk-Banaszak I, Szczepankiewicz A.
Nitric Oxide Synthase 2 Promoter Polymorphism Is a Risk Factor for Allergic Asthma in Children. Medicina. 2021; 57(12):1341.
https://doi.org/10.3390/medicina57121341
Chicago/Turabian Style
Nowakowska, Joanna, Paulina Sobkowiak, Anna Bręborowicz, Magdalena Mrówczyńska, Irena Wojsyk-Banaszak, and Aleksandra Szczepankiewicz.
2021. "Nitric Oxide Synthase 2 Promoter Polymorphism Is a Risk Factor for Allergic Asthma in Children" Medicina 57, no. 12: 1341.
https://doi.org/10.3390/medicina57121341
APA Style
Nowakowska, J., Sobkowiak, P., Bręborowicz, A., Mrówczyńska, M., Wojsyk-Banaszak, I., & Szczepankiewicz, A.
(2021). Nitric Oxide Synthase 2 Promoter Polymorphism Is a Risk Factor for Allergic Asthma in Children. Medicina, 57(12), 1341.
https://doi.org/10.3390/medicina57121341